GLOBAL SALES AND R&D
HYDROPONICS CANADA AND U.S.A. LICENSED PRODUCTS AND SALES
GROW AND IP
BREEDS AND STRAINS
THC has rapidly grown to become Australia’s Leading Medicinal Cannabis Company.
THC operates under a ‘farm to pharma’ pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through existing access schemes. Having secured both a significant growing capacity over two grow sites, and an industry-leading pharmaceuticals biomanufacturing facility, THC is in prime position to service both domestic patients and the export market.
THC’s global commercial partners operate across four continents, supporting THC’s future international growth. THC also operates a revenue generating global hydroponics business, focusing on the manufacturing and distribution of hydroponics equipment, materials, and nutrients.
Information for Health Care Providers and Patients
If you are a medical practitioner or a pharmacist, please visit the CanndeoCare website for a suite of resources, documentation, forms and information.
Latest Media Interview January 2020:
Proactive Investors interview with THC Global Group Limited CEO Mr Ken Charteris
Level 41 Australia Square
264 George Street
Sydney NSW 2000
+61 (0)2 8088 4760